The BGI Annual Report for 2020 says it is committed to promoting China’s globalization efforts and supports the Chinese Communist Party’s (CCP) “One Belt, One Road” strategy. The report shows how BGI expanded its operations across China, opened gene banks and research facilities in Xingjiang and Tibet, and is now serving customers in more than 100 countries. The CCP strategy of a “Healthy China” has enabled BGI to conduct large-scale screening and acquire biomedical data on Chinese people. The accumulated data expedites their work in building a national network of gene banks and research bases targeting Chinese citizens. BGI is using the data to conduct “precision medicine” research and applications. Plans exist to continue expanding these bases and facilities throughout China. BGI’s massive expansion plans were first revealed in 2018 by Wang Deming, Chairman of Nanjing Changjian Yujia Health Management Co. Deming was a business partner with BGI prior to …